Evidence map›Paper›PMID 14685107›Full record

Trial reportAnnals of surgery2004

Alabama coronary artery bypass grafting project: results from phase II of a statewide quality improvement initiative.

William L Holman, Monique Sansom, Catarina I Kiefe, Eric D Peterson, Steve G Hubbard, James F Delong, Richard M Allman

Abstract readClinical TrialClinical Trial, Phase IIValidation Study
In one paragraph

Trial report in Annals of surgery, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

William L HolmanBirmingham VA Medical Center, University of Alabama at Birmingham, Birmingham, AL, USA. wholman@its.uab.edu
Monique Sansom
Catarina I Kiefe
Eric D Peterson
Steve G Hubbard
James F Delong
Richard M Allman

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

OBJECTIVE/

backgroundThis report describes the first round of results for Phase II of the Alabama CABG Project, a regional quality improvement initiative.

methodsCharts submitted by all hospitals in Alabama performing CABG (ICD-9 codes 36.10-36.20) were reviewed by a Clinical Data Abstraction Center (CDAC) (preintervention 1999-2000; postintervention 2000-2001). Variables that described quality in Phase I were abstracted for Phase II and data describing the new variables of beta-blocker use and lipid management were collected. Data samples collected onsite by participating hospitals were used for rapid cycle improvement in Phase II.

resultsCDAC data (n = 1927 cases in 1999; n = 2001 cases in 2000) showed that improvements from Phase I in aspirin prescription, internal mammary artery use, and duration of intubation persisted in Phase II. During Phase II, use of beta-blockers before, during, or after CABG increased from 65% to 76% of patients (P < 0.05). Appropriate lipid management, an aggregate variable, occurred in 91% of patients before and 91% after the educational intervention. However, there were improvements in 3 of 5 subcategories for lipid management (documenting a lipid disorder [52%-57%], initiating drug therapy [45%-53%], and dietary counseling [74%-91%]; P < 0.05).

conclusionsIn Phase II, this statewide process-oriented quality improvement program added two new measures of quality. Achievements of quality improvement from Phase I persisted in Phase II, and improvements were seen in the new variables of lipid management and perioperative use of beta-blockers.

Indexed as

Quality Assurance, Health CareAdrenergic beta-AntagonistsAgedAlabamaAspirinBenchmarkingCardiology Service, HospitalCoronary Artery BypassCoronary Artery DiseaseFemaleGraft RejectionGraft SurvivalHealth Services ResearchHospital MortalityHumansMaleAdrenergic beta-AntagonistsAspirin

Identifiers

PMID14685107
PMCPMC1356199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.